Erratum to: Can We Identify Patients with High Risk of Osteoarthritis Progression Who Will Respond to Treatment? A Focus on Epidemiology and Phenotype of Osteoarthritis (Drugs & Aging, (2015), 32, 3, (179-187), 10.1007/s40266-015-0243-3)

Olivier Bruyère; Cyrus Cooper; Nigel Arden; Jaime Branco; Maria Luisa Brandi; Gabriel Herrero-Beaumont; Francis Berenbaum; Elaine Dennison; Jean Pierre Devogelaer; Marc Hochberg; John Kanis; Andrea Laslop; Tim McAlindon; Susanne Reiter; Pascal Richette; René Rizzoli; Jean Yves Reginster

ArticleOPEN ACCESS

Erratum to: Can We Identify Patients with High Risk of Osteoarthritis Progression Who Will Respond to Treatment? A Focus on Epidemiology and Phenotype of Osteoarthritis (Drugs & Aging, (2015), 32, 3, (179-187), 10.1007/s40266-015-0243-3)

Drugs and Aging

DOI: 10.1007/s40266-017-0456-8

2Citations

20Readers

Abstract

In the Original publication the affiliation for J. Kanis was incorrectly published. This previously read: WHO Collaborating Centre for Metabolic Bone Diseases, University of Sheffield Medical School, Sheffield, UK. Should read: Centre for Metabolic Bone Diseases, University of Sheffield Medical School, Sheffield, UK.

Cite

CITATION STYLE

APA

Bruyère, O., Cooper, C., Arden, N., Branco, J., Brandi, M. L., Herrero-Beaumont, G., … Reginster, J. Y. (2017, May 1). Erratum to: Can We Identify Patients with High Risk of Osteoarthritis Progression Who Will Respond to Treatment? A Focus on Epidemiology and Phenotype of Osteoarthritis (Drugs & Aging, (2015), 32, 3, (179-187), 10.1007/s40266-015-0243-3). Drugs and Aging. Springer International Publishing. https://doi.org/10.1007/s40266-017-0456-8

Erratum to: Can We Identify Patients with High Risk of Osteoarthritis Progression Who Will Respond to Treatment? A Focus on Epidemiology and Phenotype of Osteoarthritis (Drugs & Aging, (2015), 32, 3, (179-187), 10.1007/s40266-015-0243-3)

Abstract

Cite

Register to see more suggestions